Latest news
News
-
1 September 2021
Bimzelx (Bimekizumab) - NICE approves new biologic for psoriasis
Bimzelx (Bimekizumab) has been recommended for the treatment of severe psoriasis in adults in England and Wales.
-
19 August 2021
Coronavirus (COVID-19) Information
Information for people living with psoriasis and psoriatic arthritis, including those taking immunosuppressive medicines.
-
19 August 2021
What is the latest 'shielding' guidance?
Advice for people who are deemed to be 'clinically extremely vulnerable'.
-
17 August 2021
COVID-19 Vaccine and Psoriasis
Information about the COVID-19 vaccine(s), psoriasis and immunosuppressant medications.
-
10 August 2021
Top Ten Psoriatic Arthritis Research Priorities Announced
The 'Top Ten' list has been agreed upon by patients, carers and clinicians, for the Psoriatic Arthritis Priority Setting Partnership (PSP).